Elevance Health Surges to 113th in Trading Volume with $851 Million Turnover

On July 16, 2025, Elevance Health (ELV) saw a significant surge in trading volume, with a total turnover of $851 million, marking a 44.92% increase from the previous day. This substantial rise placed Elevance Health at the 113th position in terms of trading volume for the day. The stock price of Elevance Health also experienced a notable increase, rising by 2.48%.

Elevance Health is set to announce its second-quarter earnings on July 17, 2025. Analysts anticipate an earnings per share (EPS) of $8.97, which represents an 11.4% year-over-year decrease, and revenue of $48.2 billion, indicating an 11.5% year-over-year increase. The company's recent performance has shown a strong return on equity of 18.61%, with earnings per share of $11.97 for the quarter, surpassing the consensus estimate of $10.60 by $1.37.

Investors are closely watching Elevance Health's upcoming earnings report, as rising costs and lower Medicaid reimbursements may put pressure on the company's profits. The company's earnings for 2025 are projected to be $5.917 billion, with an average forecast of $7.773 billion by 19 Wall Street analysts. Elevance Health has an average rating of overweight and a mean price target of $460.83, according to analysts.